Jaime Imitola, senior author of the paper and director of the Comprehensive Multiple Sclerosis Center at UConn Health Here at CIRM we only fund clinical trials that meet the rigorous standards outlined by the Food and Drug Administration (FDA). These requirements are not only necessary to properly evaluate how effective a potential treatment may be, … Continue reading Unproven “stem cell” therapy injuries are more common than we realized